Company
GlaxoSmithKline
The drug company the hosts say acquired a stake in 23andMe as part of a four-year deal.
Mentions
310: Spark Grumpiness
-
8:18
GlaxoSmithKline has announced it is acquiring a $300 million stake in 23andMe